{"nct_id":"NCT00963547","title":"A Study of MK-2206 in Combination With Trastuzumab and Lapatinib for the Treatment of HER2+ Solid Tumors (MK-2206-015)","status":"TERMINATED","status_verified_date":"2024-05","start_date":"2009-09-15","start_date_type":"ACTUAL","primary_completion_date":"2011-08-09","primary_completion_date_type":"ACTUAL","completion_date":"2011-12-22","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["MRK"]}